Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 126

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket

Forster, Michael, Chaikuad, Apirat, Bauer, Silke M., Holstein, Julia, Robers, Matthew B., Corona, Cesear R., Gehringer, Matthias, Pfaffenrot, Ellen, Ghoreschi, Kamran, Knapp, Stefan, Laufer, Stefan A. · 2016 · Cell Chemical Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chembiol.2016.10.008

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 18

  1. Bauer, 2014, A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of Janus Kinase 3 (JAK3) inhibitors, Anal. Methods, 6, 8817, 10.1039/C4AY01589D · doi:10.1039/c4ay01589d
  2. Chrencik, 2010, Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6, J. Mol. Biol., 400, 413, 10.1016/j.jmb.2010.05.020 · DOI · Paper page
  3. Flanagan, 2010, Discovery of CP-690'550: a potent and selective Janus Kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection, J. Med. Chem., 53, 8468, 10.1021/jm1004286 · DOI · Paper page
  4. Gehringer, 2014, Design and synthesis of tricyclic JAK3 inhibitors with picomolar affinities as novel molecular probes, ChemMedChem, 9, 277, 10.1002/cmdc.201300520 · DOI
  5. Ghoreschi, 2009, Selectivity and therapeutic inhibition of kinases: to be or not to be?, Nat. Immunol., 10, 356, 10.1038/ni.1701 · DOI · Paper page
  6. Ghoreschi, 2011, Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550), J. Immunol., 186, 4234, 10.4049/jimmunol.1003668 · DOI · Paper page
  7. Haan, 2011, Jak1 has a dominant role over jak3 in signal transduction through gamma-c-containing cytokine receptors, Chem. Biol., 18, 314, 10.1016/j.chembiol.2011.01.012 · DOI · Paper page
  8. Knapp, 2013, A public-private partnership to unlock the untargeted kinome, Nat. Chem. Biol., 9, 3, 10.1038/nchembio.1113 · DOI
  9. Liu, 2013, Developing irreversible inhibitors of the protein kinase cysteinome, Chem. Biol., 20, 146, 10.1016/j.chembiol.2012.12.006 · DOI · Paper page
  10. Muller, 2015, The ins and outs of selective kinase inhibitor development, Nat. Chem. Biol., 11, 818, 10.1038/nchembio.1938 · DOI · Paper page
  11. Pesu, 2005, Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs, Immunol. Rev., 203, 127, 10.1111/j.0105-2896.2005.00220.x · DOI
  12. Robers, 2015, Target engagement and drug residence time can be observed in living cells with BRET, Nat. Commun., 6, 10091, 10.1038/ncomms10091 · DOI · Paper page
  13. Serafimova, 2012, Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles, Nat. Chem. Biol., 8, 471, 10.1038/nchembio.925 · DOI · Paper page
  14. Singh, 2010, Targeted covalent drugs of the kinase family, Curr. Opin. Chem. Biol., 14, 475, 10.1016/j.cbpa.2010.06.168 · DOI · Paper page
  15. Smith, 2016, Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling, Nat. Chem. Biol., 12, 373, 10.1038/nchembio.2056 · DOI
  16. Thoma, 2011, Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family, J. Med. Chem., 54, 284, 10.1021/jm101157q · DOI
  17. Thoma, 2014, Selective inhibitors of the Janus kinase Jak3—Are they effective?, Bioorg. Med. Chem. Lett., 24, 4617, 10.1016/j.bmcl.2014.08.046 · DOI
  18. Thorarensen, 2014, ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual jak kinase isoforms to cellular signaling, ACS Chem. Biol., 9, 1552, 10.1021/cb5002125 · DOI

Cited by

See all 126

Metadata

Authors
Forster, M., Chaikuad, A., Bauer, S. M., Holstein, J., Robers, M. B., Corona, C. R., Gehringer, M., Pfaffenrot, E., Ghoreschi, K., Knapp, S., & Laufer, S. A.
Venue
Cell Chemical Biology
Publisher
Elsevier BV
Published
2016-11
Volume
23
Issue
11
Pages
1335-1340
ISSN
2451-9456
Cited by
126
References
3
Language
en
Licence
Funders
  • Canada Foundation for Innovation
  • Takeda Pharmaceutical Company
  • Deutsche Forschungsgemeinschaft (SFB TR156)
  • Genome Canada
  • Innovative Medicines Initiative
  • Wellcome Trust (092809/Z/10/Z)
  • Pfizer
  • Ontario Genomics Institute
  • Ontario Ministry of Economic Development and Innovation
  • Boehringer Ingelheim
  • Janssen Biotech

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket. https://app.cochat.ai/papers/10.1016/j.chembiol.2016.10.008
The paper
Forster, M., Chaikuad, A., Bauer, S. M., Holstein, J., Robers, M. B., Corona, C. R., Gehringer, M., Pfaffenrot, E., Ghoreschi, K., Knapp, S., & Laufer, S. A. (2016). Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2016.10.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.